| Added by | mollevi |
|---|---|
| Group name | EquipePM |
| Item Type | Note |
| Note | The following values have no corresponding Zotero field: auth-address: OREGA Biotech, Ecully, France. jeremy.bastid@orega-biotech.com jean-francois.eliaou@inserm.fr armand.bensussan@inserm.fr. OREGA Biotech, Ecully, France. IRCM, Institut de Recherche en Cancerologie de Montpellier; INSERM, U896; Universite Montpellier 1; CRLC Val d'Aurelle Paul Lamarque, Montpellier, France. OREGA Biotech, Ecully, France. IRCM, Institut de Recherche en Cancerologie de Montpellier; INSERM, U896; Universite Montpellier 1; CRLC Val d'Aurelle Paul Lamarque, Montpellier, France. Institut Jean Godinot, Reims, France. Universite Reims-Champagne-Ardenne, DERM-I-C, EA7319, Reims Cedex, France. Institut National de la Sante et de la Recherche Medicale (INSERM) UMR-S 976; Universite Paris Diderot, Sorbonne Paris Cite, Laboratoire Immunologie Dermatologie & Oncologie, Paris, France. Institut National de la Sante et de la Recherche Medicale (INSERM) UMR-S 976; Universite Paris Diderot, Sorbonne Paris Cite, Laboratoire Immunologie Dermatologie & Oncologie, Paris, France. jeremy.bastid@orega-biotech.com jean-francois.eliaou@inserm.fr armand.bensussan@inserm.fr. IRCM, Institut de Recherche en Cancerologie de Montpellier; INSERM, U896; Universite Montpellier 1; CRLC Val d'Aurelle Paul Lamarque, Montpellier, France. Departement d'Immunologie, Centre Hospitalier Regional Universitaire de Montpellier et Faculte de Medecine Universite Montpellier 1, Montpellier, France. jeremy.bastid@orega-biotech.com jean-francois.eliaou@inserm.fr armand.bensussan@inserm.fr. alt-title: Cancer immunology research number: 3 accession-num: 25403716 |
| Tags | _EndnoteXML import |
| Date Added | 2018/07/20 - 09:15:34 |
| Date Modified | 2018/07/20 - 09:15:34 |
| Parent item | Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity |
Institut de Recherche en Cancérologie de
